Call toll-free 800.328.1267
Something unusual is happening with prices, and it's become good news for certain companies this year. Inflation data from the government shows the price of services rose 2.7 percent year over year in January, while commodities had their first drop since November...
Unusual companies advanced following their quarterly results in the last week, continuing a trend this earnings season. Consider Garmin (GRMN) and Arista Networks (ANET), the two biggest gainers in the S&P 500 since our last review. GRMN, a one-time leader in GPS...
Stocks kept rallying last week as one fear after another seemed to evaporate. Government shutdown? Nope. Trade war with China? Probably not if talks continue. Recession? Just when it looked like things were slowing down, the data turned positive. The pessimists just...
Stocks drifted last week as investors started worrying about politics and the global economy. The S&P 500 rose less than 0.1 percent between Friday, February 1, and Friday, February 8. It was only the sixth and smallest advance in the last seven weeks, following...
Many high profile technology stocks have rebounded this earnings season. Video-game makers aren't so lucky. Check out the three worst performing members of the S&P 500 and Nasdaq-100 today. No company is even close to these drops in either index: Electronic Arts...
TradeStation clients kept their focus on the Nasdaq in January, with stocks on the exchange enjoying their biggest rally in three years. Nine of the 10 busiest symbols on our platform last month were listed on the Nasdaq. Most of the top names were prominent large-cap...
Stocks rallied for a fourth straight week amid good earnings, positive economic news and signs of progress in the trade war with China. The S&P 500 rose 2.9 percent between Friday, January 11, and Friday, January 18. The index is in the midst of its longest weekly...
Earnings season began on a strong foot, thanks to financials and a handful of other key stocks. Bank of America (BAC), Goldman Sachs (GS) and Citigroup (C) led the charge. Stronger banking activity was the big driver, also lifting smaller regionals like Comerica (CMA)...
Biotechnology stocks are ripping in 2019, fueled by some high-profile takeovers. It was only the second trading session of the year that Bristol Myers Squibb (BMY) gobbled up Celgene (CELG) in a record $74 billion deal. Loxo Oncology (LOXO) accepted an $8 billion bid...